Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b93320d3a89ea67160708254e642086 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
filingDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90621c1b73381f7c4253892f5c276901 |
publicationDate |
2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008274111-A1 |
titleOfInvention |
Pancreatic Cancer Genes |
abstract |
The present invention provides the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia. These polynucleotides and encoded proteins or polypeptides can be used in the diagnosis or identification of cancer and dysplasia. Inhibitors of the up-regulated polynucleotides and proteins can decrease the abnormality of cancer and dysplasia. Enhancing the expression of down-regulated polynucleotides or introducing down-regulated proteins to cells can decrease the growth and/or abnormal characteristics of cancer and dysplasia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030455-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863423-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324272-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009275734-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460873-B2 |
priorityDate |
1998-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |